HighTower Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $709K | Sell |
|
|||||
|
2025
Q1 | $898K | Sell |
|
|||||
|
2024
Q4 | $1.24M | Sell |
|
|||||
|
2024
Q3 | $2.05M | Sell |
|
|||||
|
2024
Q2 | $2.27M | Sell |
|
|||||
|
2024
Q1 | $3.27M | Buy |
|
|||||
|
2023
Q4 | $2.65M | Sell |
|
|||||
|
2023
Q3 | $2.76M | Sell |
|
|||||
|
2023
Q2 | $3.01M | Sell |
|
|||||
|
2023
Q1 | $3.72M | Sell |
|
|||||
|
2022
Q4 | $7.35M | Buy |
|
|||||
|
2022
Q3 | $5.53M | Buy |
|
|||||
|
2022
Q2 | $4.48M | Sell |
|
|||||
|
2022
Q1 | $8.63M | Sell |
|
|||||
|
2021
Q4 | $11.7M | Buy |
|
|||||
|
2021
Q3 | $7.86M | Buy |
|
|||||
|
2021
Q2 | $7.02M | Buy |
|
|||||
|
2021
Q1 | $5.29M | Buy |
|
|||||
|
2020
Q4 | $4.13M | Buy |
|
|||||
|
2020
Q3 | $3.75M | Buy |
|
|||||
|
2020
Q2 | $2.81M | Buy |
|
|||||
|
2020
Q1 | $1.88M | Buy |
|
|||||
|
2019
Q4 | $2.25M | Buy |
|
|||||
|
2019
Q3 | $1.9M | Buy |
|
|||||
|
2019
Q2 | $1.99M | Buy |
|
|||||
|
2019
Q1 | $1.97M | Buy |
|
|||||
|
2018
Q4 | $1.46M | Buy |
|
|||||
|
2018
Q3 | $831K | Buy |
|
|||||
|
2018
Q2 | $590K | Sell |
|
|||||
|
2018
Q1 | $987K | Buy |
|
|||||
|
2017
Q4 | $478K | Sell |
|
|||||
|
2017
Q3 | $586K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $714K | Buy |
|